Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity
hLife
· Elsevier
The publisher did not provide an abstract — full text is available via the link below.
Read at publisher →
Citation
Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity. // hLife. – URL: https://www.sciencedirect.com/science/article/pii/S2949928326000581?dgcid=rss_sd_all
Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity. hLife. https://www.sciencedirect.com/science/article/pii/S2949928326000581?dgcid=rss_sd_all
“Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity.” hLife.
@article{article3661,
title = {Rationally designed common-light-chain anti-EGFR/c-MET bispecific antibody ALK101 demonstrates potent, broad-spectrum antitumor activity},
journal = {hLife},
url = {https://www.sciencedirect.com/science/article/pii/S2949928326000581?dgcid=rss_sd_all}
}